GUFICBIO
Gufic Biosciences Limited (GUFICBIO) Stock Analysis
Gufic Biosciences Limited is an Indian pharmaceutical company focused on critical care and injectable therapies. It manufactures anaesthetics, ICU medicines, and lyophilized products. The company serves hospitals across India. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹406.30
-2.89% 1W | +15.70% 52W
Market Cap
4.1k CR
P/E Ratio
55.5
52W High
₹467.8
52W Low
₹268
Div. Yield
0.02%
Beta
-0
50 DMA
₹420.6
200 DMA
₹345.9
Profit Margin
7.5%
Inst. Own.
3.5%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 215 | 202 | 195 | 203 | 204 | 208 | 205 | 224 | 237 | 231 | 252 | 261 |
| Expenses | 176 | 165 | 161 | 167 | 166 | 174 | 179 | 190 | 199 | 198 | 205 | 214 |
| Operating Profit | 39 | 36 | 34 | 36 | 39 | 34 | 26 | 33 | 38 | 33 | 47 | 47 |
| OPM % | 18% | 18% | 18% | 18% | 19% | 16% | 13% | 15% | 16% | 14% | 19% | 18% |
| Other Income | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 1 | 2 | 1 | -1 | 0 |
| Interest | 4 | 3 | 4 | 5 | 5 | 5 | 8 | 9 | 10 | 8 | 9 | 9 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 8 | 8 | 8 | 8 | 8 | 8 |
| Profit before tax | 31 | 30 | 27 | 28 | 29 | 26 | 11 | 17 | 23 | 18 | 29 | 30 |
| Tax % | 25% | 25% | 26% | 26% | 26% | 26% | 27% | 24% | 26% | 30% | 24% | 26% |
| Net Profit | 23 | 22 | 20 | 21 | 22 | 19 | 8 | 13 | 17 | 12 | 22 | 22 |
| EPS in Rs | 2.39 | 2.22 | 2.00 | 2.08 | 2.17 | 1.93 | 0.77 | 1.30 | 1.68 | 1.24 | 2.18 | 2.22 |
| Metric | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 807 | 820 | 944 | 981 |
| Expenses | 657 | 684 | 793 | 816 |
| Operating Profit | 150 | 136 | 151 | 165 |
| OPM % | 19% | 17% | 16% | 17% |
| Other Income | -0 | 4 | 3 | 2 |
| Interest | 17 | 25 | 37 | 37 |
| Depreciation | 17 | 21 | 31 | 31 |
| Profit before tax | 116 | 94 | 87 | 99 |
| Tax % | 26% | 26% | 26% | |
| Net Profit | 86 | 70 | 64 | 73 |
| EPS in Rs | 8.59 | 6.95 | 6.40 | 7.32 |
| Dividend Payout % | 1% | 1% | 2% |
Shareholding Pattern
Promoters72.51%
FIIs0.32%
DIIs3.38%
Public23.81%
Promoters72.50%
FIIs0.33%
DIIs3.66%
Public23.51%
Promoters72.50%
FIIs0.44%
DIIs3.74%
Public23.30%
Promoters72.50%
FIIs0.42%
DIIs3.83%
Public23.23%
Promoters72.50%
FIIs0.47%
DIIs3.67%
Public23.36%
Promoters75.00%
FIIs0.72%
DIIs1.16%
Public23.12%
Promoters72.51%
FIIs0.12%
DIIs2.20%
Public25.17%
Promoters72.51%
FIIs0.31%
DIIs3.39%
Public23.79%
Promoters72.50%
FIIs0.42%
DIIs3.83%
Public23.23%
Promoters72.50%
FIIs0.47%
DIIs3.67%
Public23.36%
GUFICBIO
Holdings Analysis
Key strengths & risk signals
60
Overall
49
Fundamental
72
Technical
Risks (3)
Cannot calculate PEG - insufficient growth data.
RECOVERY MODE! Current price (406.3) above 200-day but below 50-day.
WEAK MOMENTUM! Limited price growth - -2.9% (1 week), -5.3% (1 month), 3.5% (3 months).
Strengths (4)
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
BULLISH TREND! 50-day average (420.6) is above 200-day average (345.9) - positive signal.
BULLISH SENTIMENT! In last 30 days: 16 up days, 13 down days. Avg volume on up days: 138,148 vs down days: 88,695. Ratio: 1.56x
UPPER HALF! Trading at 69.2% of 52W range - positive territory.
Fundamental & Technical Analysis
60Overall
49Fundamental
72Technical
Fundamental Breakdown
Growth Quality
10/30
Revenue CAGR: 6.1% (MODERATE, 8/15). Profit CAGR: -6.9% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 7.5% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.02% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 23.12% public ownership - balanced ownership structure.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (420.6) is above 200-day average (345.9) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (406.3) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
6/10
POSITIVE YEAR! Stock gained 15.7% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 16 up days, 13 down days. Avg volume on up days: 138,148 vs down days: 88,695. Ratio: 1.56x
RSI
3/5
NEUTRAL! RSI at 41.5 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 69.2% of 52W range - positive territory.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -2.9% (1 week), -5.3% (1 month), 3.5% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GUFICBIO | ₹406.30 | 55.5 | 7.5% | 6.1% | -6.9% | +15.7% | 60 | BREAKDOWN | +70.2% | +1.8% | +16.6% | +3.6% |
| AARTIDRUGS | ₹413.30 | 19.7 | 7.1% | -2.3% | 5.4% | -17.9% | 57 | BOUNCE FROM SUPPORT | -6.9% | -9.1% | +19.0% | -2.4% |
| UNICHEMLAB | ₹531.10 | 12.3 | 13.2% | 18.4% | – | +12.3% | 64 | BREAKDOWN | -495.2% | +280.7% | +20.1% | +10.0% |
| RPGLIFE | ₹2,719.20 | 37.6 | 16.3% | 11.3% | 19.4% | +27.6% | 75 | APPROACHING SUPPORT | +17.1% | +3.0% | +15.9% | +10.6% |
| GUJTHEM | ₹363.50 | 81.3 | 28.0% | 3.8% | -7.0% | -9.7% | 58 | BREAKDOWN | +22.0% | +1.8% | +22.0% | -0.9% |
| ORCHPHARMA | ₹984.00 | 611.1 | 3.5% | 22.3% | -40.1% | +37.3% | 67 | APPROACHING RESISTANCE | -156.1% | -86.6% | +15.6% | +28.0% |
| SOLARA | ₹644.40 | – | -0.1% | -1.2% | – | +14.8% | 53 | CONSOLIDATING DOWN | +55.2% | +69.8% | +19.5% | -1.5% |
| INDSWFTLAB | ₹360.90 | 53.9 | 8.5% | -19.7% | -3.2% | +249.6% | 59 | BREAKDOWN | +180.7% | +63.6% | +21.0% | +12.8% |
Data from TradeAlone · Updated daily
No news tagged for GUFICBIO yet.
